Sodium Channelopathies in Epileptic Encephalopathies

Epileptic encephalopathies are severe early-onset disorders resulting from mutations in the genes encoding voltage-gated sodium channels. These channels regulate the initiation and propagation of action potentials in the central nervous system and are encoded by a family of SCN genes, among which SCN1A, SCN2A and SCN8A are most frequently implicated. Pathogenic variants can alter channel biophysics by shifting activation or inactivation thresholds, modifying current density or gating kinetics. Gain-of-function mutations typically increase neuronal excitability by enhancing persistent or resurgent sodium currents, whereas loss-of-function mutations impair action potential generation, often leading to network dysfunction. Clinically these channelopathies manifest as developmental delays, refractory seizures and neurocognitive regression, with some syndromes such as Dravet and SCN8A encephalopathy carrying high mortality. Advances in functional characterisation, including cell-type and isoform-specific assays, have refined genotype–phenotype correlations and identified molecular mechanisms that can guide precision medicine. For example, sodium channel blockers remain a mainstay for certain gain-of-function mutants, but may exacerbate symptoms in cases of loss-of-function. Emerging therapeutic strategies include gene-targeted RNA interference, antisense oligonucleotides and immunomodulatory approaches. Understanding genetic modifiers and compensatory ion channel interactions has highlighted the potential to harness endogenous rescue mechanisms. Global efforts in genetic screening and phenotypic characterisation underpin a precision-guided framework for diagnosis and treatment, aiming to attenuate seizures while minimising developmental impact.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Sodium Channelopathies in Epileptic Encephalopathies publication trend

The graph below shows the total number of articles in sodium channelopathies in epileptic encephalopathies across all publications each year (not limited to Nature Index journals).

Technical terms

Voltage-gated sodium channel: A membrane protein that opens in response to changes in electrical potential, allowing sodium ions to enter neurons and initiate action potentials.

Gain-of-function mutation: A genetic alteration that increases the activity of a protein, often leading to excessive neuronal firing in this context.

Loss-of-function mutation: A mutation that reduces or abolishes the normal activity of a protein, which can disrupt neuronal signalling.

Persistent current: A non-inactivating sodium current that continues after the initial action potential, contributing to neuronal hyperexcitability.

Resurgent current: A sodium current that reactivates during repolarisation, facilitating rapid repetitive firing of neurons.

Epileptic encephalopathy: A severe neurological disorder characterised by early-onset seizures, developmental impairment and often progressive cognitive decline.

References

1. Molecular and cellular context influences SCN8A variant function. JCI Insight (2024).
2. Voltage-Gated Ion Channel Compensatory Effect in DEE: Implications for Future Therapies. Cells (2024).
3. Anti‐PD‐1 treatment protects against seizure by suppressing sodium channel function. CNS Neuroscience & Therapeutics (2023).